A Democratic amendment with no cosponsors
Changes S.Con.Res. 7 — An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Offered
Offered, and not voted on yet. Most amendments never get a vote: the Senate takes up the bill and moves on without them.
Its path through Congress
- Introduced
- Pending Consideration
What this amendment would do
Mr. Merkley submitted amendment SA 597 to be proposed to the concurrent resolution on the budget for fiscal year 2025. The purpose of this amendment is to add a deficit-neutral reserve fund relating to reducing federal health program spending for prescription drugs.
The amendment aims to allow the Chairman of the Senate Committee on the Budget to revise allocations, aggregates, and other levels, and make adjustments to the pay-as-you-go ledger. This is for legislation relating to reducing health care costs, provided that the legislation does not increase the deficit from fiscal years 2025 through 2034.
- Establish international reference prices so the United States may purchase prescription drugs at the lowest prices available among similarly developed countries.
- Require pharmaceutical manufacturers to report annually the amount of taxpayer dollars used to benefit manufacturers' research and development efforts.
- Use other mechanisms to purchase prescription drugs at lower prices.
- 2/20/2025
- Senate amendment submitted
This bill has no cosponsors